Skip to main content

Table 2 Pathological diagnoses of the 144 adnexal masses

From: Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study

Histology

Overall

Premenopausal

Postmenopausal

Number of masses

144

82

62

Benign masses, n(%)

104 (72.22)

73 (89.02)

31 (50.00)

ā€ƒTeratoma

32 (30.77)

27 (36.99)

5 (16.13)

ā€ƒSimple/functional cyst

27 (25.96)

21 (28.77)

6 (19.35)

ā€ƒSerous cystadenoma

10 (9.62)

6 (8.22)

4 (12.90)

ā€ƒMucinous cystadenoma

4 (3.85)

3 (4.11)

1 (3.22)

ā€ƒOvarian endometrial cyst

5 (4.81)

4 (5.48)

1 (3.22)

ā€ƒFibroma

11 (10.58)

3 (4.11)

8 (25.81)

ā€ƒHydrosalpinx

8 (7.69)

5 (6.85)

3 (9.68)

ā€ƒTubo-ovarian abscess

3 (2.88)

0 (0)

3 (9.68)

ā€ƒOther benign masses

4 (3.85)

4 (5.48)

0 (0)

Malignant masses, n(%)

40 (27.78)

9 (10.98)

31 (50.00)

ā€ƒSerous cystadenocarcinoma

25 (62.50)

3 (33.33)

22 (70.97)

ā€ƒClear-cell carcinoma

4 (10.00)

2 (22.22)

2 (6.45)

ā€ƒGranulosa-cell tumor

3 (7.50)

2 (22.22)

1 (3.22)

ā€ƒMucinous adenocarcinoma

2 (5.00)

0 (0)

2 (6.45)

ā€ƒMetastasis

3 (7.50)

0 (0)

3 (9.68)

ā€ƒCarcinosarcoma

1 (2.50)

1 (11.11)

0 (0)

ā€ƒEndometrioid carcinoma

1 (2.50)

0 (0)

1 (3.22)

ā€ƒDisgerminoma

1 (2.50)

1 (11.11)

0 (0)